David Einhorn Bets on Aluminum in Q3: Here Are His New Stock Picks, Fund Changes
DME Capital Management reveals its new third-quarter stock picks. Here's what David Einhorn has been buying.
Last updated: 2026-11-19 02:28:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Teva Pharmaceutical Industries Limited (TEVA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $42.24, with a market capitalization of $49.67B and a P/E ratio of 97.89. Over the past 52 weeks, its price has ranged from $24.01 to $44.57. This page covers its latest market performance, valuation, price trends and company information.
$49.67B | |
$42.75 | |
$43.02 | |
$42.05 | |
$42.62 | |
6.93M | |
6.13M | |
97.89 | |
$44.57 | |
$24.01 | |
-- | |
2026-09-30 |
Teva Pharmaceutical Industries Limited (TEVA) last closed at $42.24 as of 2026-11-19 00:56:54, down 1.45% ($0.62) from the previous close of $42.62.
During the latest regular trading session, TEVA traded between $42.05 and $43.02, with a volume of 6.93M shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Teva Pharmaceutical Industries Limited (TEVA) moved from $42.97 to $42.24, representing a decline of 1.70% ($0.73).
The stock traded between $41.52 and $44.57 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 7.38 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 88.7%
TEVA is currently trading at $42.24, placing it 88.7% of the way from its 52-week low of $24.01 to its 52-week high of $44.57. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 32,842 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Teva Pharmaceutical Industries Limited.
Dividend | |
|---|---|
| Ex-Dividend Date | Nov 27, 2017 |
| Payment Date | Dec 12, 2017 |
| Dividend Per Share | $0.085 |
Latest news related to Teva Pharmaceutical Industries Limited and TEVA stock.
DME Capital Management reveals its new third-quarter stock picks. Here's what David Einhorn has been buying.
HC Wainwright & Co. analyst Douglas Tsao reiterates Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and maintains $54 price target.
The FDA approved Teva's IGALMI sublingual film as the first at-home treatment for adult agitation in schizophrenia or bipolar disorder.
Milestone supports Teva’s Pivot to Growth strategy and adds to company’s commitment to patient-centered innovation in neuroscience
Piper Sandler analyst David Amsellem maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight and raises the price target from $44 to $56.
Eligible investors can buy real shares of Teva Pharmaceutical Industries Limited (TEVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to TEVA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between TEVA shares and USD.
TEVA Shares to USD
1.00 TEVA shares = 42.24 USD
Calculations are estimates based on the latest available price and are for reference only.